Target intelligence / Profile preview

5S ribosomal RNA pseudogene 429 (RNA5SP429)

Target
RNA5SP429
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, 5S ribosomal pseudogene 429 (RNA5SP429) is a **processed pseudogene** of the 5S ribosomal RNA gene, and as such, it is a non-functional, non-coding genetic sequence incorporated into the genome via retrotransposon mechanisms[2]. While functional 5S ribosomal RNA is a necessary component of the ribosome's large subunit and essential for protein synthesis and cell viability[1][3], its pseudogenes, including RNA5SP429, lack known protein-coding or direct biological activity. Some pseudogenes may be transcribed and contribute to the regulation of their coding counterparts or act as non-coding RNAs influencing gene expression networks[2][4]. However, there are no established roles for RNA5SP429 in disease, no drugs targeting it, and it is not considered a therapeutic target. The target name includes redundant and misleading formats; the most scientifically accurate is "5S ribosomal RNA pseudogene 429." This target is not a classical receptor, transporter, enzyme, or therapeutic target, and its inclusion in drug target lists may be an error or artifact from genome annotation pipelines; thus, "is_incorrect" is set to true.

Other names
RN5S429RNA, 5S ribosomal 429RNA5SP4295S ribosomal RNA pseudogene 429
02

Mechanism of action

None (not a druggable target; general mechanisms for expressed pseudogenes may involve miRNA sponging or regulatory interference[4])

03

Biological functions

Other (pseudogenes generally lack direct biological function, though some may be transcribed and potentially regulate other RNA molecules[2][4])
04

Disease associations

Other (no established links to major diseases; functional 5S rRNA, not pseudogenes, is critical for ribosome assembly and cell survival[1][3]. Pseudogenes can potentially play roles as competing endogenous RNAs or regulatory lncRNAs in certain disease states[2][4])
05

Safety considerations

None (not therapeutically targeted)
06

Interacting drugs

None (no drugs known to specifically target this pseudogene)
07

Biomarkers

None established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 429 (RNA5SP429).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 429 (RNA5SP429).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call